Ameriprise Financial Inc Astrazeneca PLC Transaction History

Ameriprise Financial Inc

  • $358 Billion
  • Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 4,850,791 shares of AZN stock, worth $378 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,850,791
Previous 4,444,604 9.14%
Holding current value
$378 Million
Previous $299 Million 9.79%
% of portfolio
0.09%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$61.03 - $69.57 $24.8 Million - $28.3 Million
406,187 Added 9.14%
4,850,791 $329 Million
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $12.5 Million - $14 Million
201,896 Added 4.76%
4,444,604 $299 Million
Q3 2023

Nov 14, 2023
BUY
$64.85 - $71.7 $13 Million - $14.4 Million
201,104 Added 4.98%
4,242,708 $287 Million
Q2 2023

Aug 14, 2023
BUY
$69.91 - $75.81 $58.1 Million - $63 Million
831,470 Added 25.9%
4,041,604 $289 Million
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $1.56 Million - $1.77 Million
-24,733 Reduced 0.76%
3,210,134 $223 Million
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $15.3 Million - $19.9 Million
-282,222 Reduced 8.02%
3,234,867 $219 Million
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $8.93 Million - $22.9 Million
-168,418 Reduced 4.57%
3,517,089 $193 Million
Q2 2022

Aug 15, 2022
SELL
$59.26 - $71.14 $16.3 Million - $19.6 Million
-275,666 Reduced 6.96%
3,685,507 $243 Million
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $12 Million - $14.4 Million
214,937 Added 5.74%
3,961,173 $263 Million
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $54.6 Million - $64.6 Million
1,011,472 Added 36.99%
3,746,236 $218 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $139 Million - $153 Million
2,508,987 Added 1111.27%
2,734,764 $164 Million
Q2 2021

Aug 16, 2021
SELL
$48.42 - $60.18 $5.58 Million - $6.94 Million
-115,313 Reduced 33.81%
225,777 $13.5 Million
Q1 2021

May 17, 2021
SELL
$47.16 - $54.44 $984,983 - $1.14 Million
-20,886 Reduced 5.77%
341,090 $17 Million
Q4 2020

Feb 12, 2021
BUY
$48.52 - $58.02 $4.04 Million - $4.83 Million
83,294 Added 29.89%
361,976 $18.1 Million
Q3 2020

Nov 16, 2020
SELL
$53.07 - $61.1 $3.67 Million - $4.22 Million
-69,061 Reduced 19.86%
278,682 $15.3 Million
Q2 2020

Aug 14, 2020
SELL
$43.1 - $55.31 $969,319 - $1.24 Million
-22,490 Reduced 6.07%
347,743 $18.4 Million
Q1 2020

May 15, 2020
BUY
$37.79 - $51.33 $165,520 - $224,825
4,380 Added 1.2%
370,233 $16.5 Million
Q4 2019

Feb 14, 2020
BUY
$42.46 - $50.46 $1.56 Million - $1.86 Million
36,805 Added 11.19%
365,853 $18.2 Million
Q3 2019

Nov 14, 2019
SELL
$40.12 - $45.47 $55,245 - $62,612
-1,377 Reduced 0.42%
329,048 $14.7 Million
Q2 2019

Aug 14, 2019
SELL
$37.28 - $41.68 $4.11 Million - $4.59 Million
-110,142 Reduced 25.0%
330,425 $13.6 Million
Q1 2019

May 15, 2019
SELL
$35.49 - $43.02 $8.29 Million - $10.1 Million
-233,718 Reduced 34.66%
440,567 $17.8 Million
Q4 2018

Feb 14, 2019
BUY
$36.86 - $41.49 $862,966 - $971,363
23,412 Added 3.6%
674,285 $25.6 Million
Q3 2018

Nov 14, 2018
SELL
$34.76 - $39.72 $60.3 Million - $68.9 Million
-1,735,824 Reduced 72.73%
650,873 $25.8 Million
Q2 2018

Aug 14, 2018
SELL
$34.55 - $37.05 $21 Million - $22.5 Million
-607,129 Reduced 20.28%
2,386,697 $83.9 Million
Q1 2018

May 15, 2018
SELL
$32.97 - $36.63 $5.55 Million - $6.16 Million
-168,227 Reduced 5.32%
2,993,826 $105 Million
Q4 2017

Feb 12, 2018
BUY
$32.09 - $34.78 $4.34 Million - $4.7 Million
135,272 Added 4.47%
3,162,053 $110 Million
Q3 2017

Nov 07, 2017
BUY
$28.96 - $34.0 $87.7 Million - $103 Million
3,026,781
3,026,781 $103 Million

Others Institutions Holding AZN

# of Institutions
1,244
Shares Held
477M
Call Options Held
5.99M
Put Options Held
5.24M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email